Yorktown Management & Research Company’s Teradyne TER Stock Holding History

Yorktown Management & Research Company’s Portfolio TER Stock Details TER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,000	Closed	-$338K	–	239
2024 Q1	$338K	Hold	3,000	–	–	0.32%	139
2023 Q4	$326K	Hold	3,000	–	–	0.34%	151
2023 Q3	$301K	Sell	3,000 -1,854	-38%	-$196K	0.34%	139
2023 Q2	$540K	Hold	4,854	–	–	0.58%	59
2023 Q1	$522K	Hold	4,854	–	–	0.56%	59
2022 Q4	$424K	Buy	+4,854	New	+$416K	0.52%	74
2022 Q3	–	Sell	-4,154	Closed	-$372K	–	225
2022 Q2	$372K	Buy	4,154 +2,300	+124%	+$239K	0.48%	90
2022 Q1	$219K	Buy	+1,854	New	+$235K	0.19%	202

Other funds holding TER

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Yorktown Management & Research Company's TER Position: Q2 2024 in Review

Yorktown Management & Research Company sold out of Teradyne (TER) in Q2 2024, closing a stake of 3,000 shares — an estimated $338K sold.

Yorktown Management & Research Company first reported a position in TER in Q1 2022 and held it in 8 quarters. The position peaked at $540K in Q2 2023. 754 funds tracked by Wall St. Rank hold TER as of Q2 2024.

Yorktown Management & Research Company reported no remaining Teradyne position as of Q2 2024 after selling out during the quarter.
Yorktown Management & Research Company sold 3,000 Teradyne shares in Q2 2024, an estimated $338K.
Yorktown Management & Research Company first reported a position in Teradyne in Q1 2022 and held it in 8 quarters.
Yorktown Management & Research Company's Teradyne position peaked at $540K in Q2 2023.
754 funds tracked by Wall St. Rank held Teradyne as of Q2 2024.

Based on Yorktown Management & Research Company's 13F filing for Q2 2024, filed 30 Jul 2024.